246 related articles for article (PubMed ID: 21159633)
21. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis.
Syed Z; Cheepala SB; Gill JN; Stein J; Nathan C; Digiovanni J; Batra V; Adegboyega P; Kleiner HE; Clifford JL
Cancer Prev Res (Phila); 2009 Oct; 2(10):903-11. PubMed ID: 19789299
[TBL] [Abstract][Full Text] [Related]
22. Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Charron J; Khavari PA
Cancer Res; 2009 May; 69(9):3772-8. PubMed ID: 19383924
[TBL] [Abstract][Full Text] [Related]
23. XB130 deficiency enhances carcinogen-induced skin tumorigenesis.
Cho HR; Wang Y; Bai X; Xiang YY; Lu C; Post A; Al Habeeb A; Liu M
Carcinogenesis; 2019 Nov; 40(11):1363-1375. PubMed ID: 30820526
[TBL] [Abstract][Full Text] [Related]
24. Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester.
Ikuta S; Edamatsu H; Li M; Hu L; Kataoka T
Cancer Res; 2008 Jan; 68(1):64-72. PubMed ID: 18172297
[TBL] [Abstract][Full Text] [Related]
25. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.
Bai Y; Edamatsu H; Maeda S; Saito H; Suzuki N; Satoh T; Kataoka T
Cancer Res; 2004 Dec; 64(24):8808-10. PubMed ID: 15604236
[TBL] [Abstract][Full Text] [Related]
26. Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.
Carr TD; Feehan RP; Hall MN; Rüegg MA; Shantz LM
Carcinogenesis; 2015 Apr; 36(4):487-97. PubMed ID: 25740823
[TBL] [Abstract][Full Text] [Related]
27. Prevention of carcinogen and inflammation-induced dermal cancer by oral rapamycin includes reducing genetic damage.
Dao V; Pandeswara S; Liu Y; Hurez V; Dodds S; Callaway D; Liu A; Hasty P; Sharp ZD; Curiel TJ
Cancer Prev Res (Phila); 2015 May; 8(5):400-9. PubMed ID: 25736275
[TBL] [Abstract][Full Text] [Related]
28. T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis.
Cataisson C; Salcedo R; Michalowski AM; Klosterman M; Naik S; Li L; Pan MJ; Sweet A; Chen JQ; Kostecka LG; Karwan M; Smith L; Dai RM; Stewart CA; Lyakh L; Hsieh WT; Khan A; Yang H; Lee M; Trinchieri G; Yuspa SH
Mol Cancer Res; 2019 Aug; 17(8):1759-1773. PubMed ID: 31164412
[TBL] [Abstract][Full Text] [Related]
29. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
30. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.
Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS
Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675
[TBL] [Abstract][Full Text] [Related]
31. Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.
Kong YH; Xu SP
Oncol Rep; 2018 Jun; 39(6):2513-2526. PubMed ID: 29693192
[TBL] [Abstract][Full Text] [Related]
32. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion.
Oberyszyn TM; Sabourin CL; Bijur GN; Oberyszyn AS; Boros LG; Robertson FM
Mol Carcinog; 1993; 7(4):238-48. PubMed ID: 8352883
[TBL] [Abstract][Full Text] [Related]
35. The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR mice.
Kowalczyk P; Junco JJ; Kowalczyk MC; Sosnowska R; Tolstykh O; Walaszek Z; Hanausek M; Slaga TJ
Mol Carcinog; 2014 Jun; 53(6):488-97. PubMed ID: 23852815
[TBL] [Abstract][Full Text] [Related]
36. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner.
Zhou H; Zhao Q; Yue C; Yu J; Zheng H; Hu J; Hu Z; Zhang H; Teng X; Liu X; Wei X; Zhou Y; Zeng F; Hao Y; Hu Y; Wang X; Zhang C; Gu L; Wu W; Zhou Y; Cui K; Huang N; Li W; Wang Z; Li J
EMBO Rep; 2022 Jun; 23(6):e53791. PubMed ID: 35578812
[TBL] [Abstract][Full Text] [Related]
38. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.
Skarin T; Rozell BL; Bergman J; Toftgård R; Möller L
Chem Biol Interact; 1999 Sep; 122(2):89-106. PubMed ID: 10528995
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
[TBL] [Abstract][Full Text] [Related]
40. PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors.
Mohanan S; Horibata S; Anguish LJ; Mukai C; Sams K; McElwee JL; McLean D; Yan A; Coonrod SA
Cell Tissue Res; 2017 Nov; 370(2):275-283. PubMed ID: 28766045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
